Latest Breaking News On - Darin lippoldt - Page 5 : comparemela.com

Los Angeles Capital Management LLC Buys 2,807 Shares of Neurocrine Biosciences, Inc (NASDAQ:NBIX)

Los Angeles Capital Management LLC Buys 2,807 Shares of Neurocrine Biosciences, Inc (NASDAQ:NBIX)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Los angelesUnited statesRobertw bairdStifel nicolausWilliamh rastetterNeurocrine biosciencesDarin lippoldtSecurities exchange commissionKb financial partnersNeurocrine biosciences company profileBluepath capital managementNeurocrine biosciences incWells fargo companyCovestor ltdLos angeles capital managementBessemer group inc

Lmcg Investments LLC Acquires 193 Shares of Neurocrine Biosciences, Inc (NASDAQ:NBIX)

Lmcg Investments LLC Acquires 193 Shares of Neurocrine Biosciences, Inc (NASDAQ:NBIX)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Neurocrine biosciencesRaymond jamesEiry robertsStifel nicolausRobertw bairdDarin lippoldtAcadian asset managementSecurities exchange commissionLmcg investmentsDeutsche bank aktiengesellschaftBessemer group incCovestor ltdKb financial partnersBluepath capital managementNeurocrine biosciences incCanaccord genuity group

Barclays Raises Neurocrine Biosciences (NASDAQ:NBIX) Price Target to $150 00

Barclays Raises Neurocrine Biosciences (NASDAQ:NBIX) Price Target to $150 00
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Nova scotiaNeurocrine biosciencesRobertw bairdDarin lippoldtStifel nicolausWilliamh rastetterNeurocrine biosciences incSecurities exchange commissionBlackrock incRoyal bankIeq capitalNorges bankGet free reportDirector williamExchange commissionNeurocrine biosciences daily

Rice Hall James & Associates LLC Sells 2,857 Shares of Neurocrine Biosciences, Inc (NASDAQ:NBIX)

Rice Hall James & Associates LLC Sells 2,857 Shares of Neurocrine Biosciences, Inc (NASDAQ:NBIX)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Neurocrine biosciencesKevin charles gormanStifel nicolausDarin lippoldtCovestor ltdRice hall james associatesDeutsche bank aktiengesellschaftAcadian asset managementBluepath capital managementKb financial partnersNeurocrine biosciences incBessemer group incRice hall jamesFree reportHall jamesAsset management

Neurocrine Biosciences, Inc (NASDAQ:NBIX) Receives $131 71 Average Price Target from Analysts

Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Get Free Report) has been assigned an average recommendation of “Moderate Buy” from the twenty-three analysts that are currently covering the firm, MarketBeat.com reports. Six analysts have rated the stock with a hold rating and seventeen have given a buy rating to the company. The average 12 month price target […]

Eiry robertsDarin lippoldtNeurocrine biosciencesJacobs levy equity management incSecurities exchange commissionCanaccord genuity groupJpmorgan chase coNeurocrine biosciences incWalleye capitalGet free reportExchange commissionLevy equity managementCreative planningGet freeNeurocrine biosciences dailyNasdaq nbix